The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111304883 11130488 3 F 20160503 20150522 20160823 PER US-ASTRAZENECA-2011SE44362 ASTRAZENECA 0.00 F Y 59.00000 KG 20160823 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111304883 11130488 1 PS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral U U 21153 40 MG CAPSULE QD
111304883 11130488 2 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral U U 0 10 MG TABLET QD
111304883 11130488 3 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral U U 0 10 MG TABLET QD
111304883 11130488 4 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral U U 0 10 MG TABLET QD
111304883 11130488 5 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral U U 0 10 MG TABLET QD
111304883 11130488 6 SS LISINOPRIL HCTZ HYDROCHLOROTHIAZIDELISINOPRIL 1 Oral 10-12.5 MG,TWICE A DAY U U 0 TABLET
111304883 11130488 7 SS ATENOLOL. ATENOLOL 1 Unknown U 0
111304883 11130488 8 SS ATENOLOL. ATENOLOL 1 Oral U 0 50 MG QD
111304883 11130488 9 SS LIPITOR ATORVASTATIN CALCIUM 1 Unknown U 0
111304883 11130488 10 C HCTZ HYDROCHLOROTHIAZIDE 1 0
111304883 11130488 11 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral 5.0MG UNKNOWN 0 5 MG
111304883 11130488 12 C CLARITIN LORATADINE 1 0 1 DF QD
111304883 11130488 13 C ALENDRONATE ALENDRONATE SODIUM 1 0 70 MG /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111304883 11130488 1 Gastrooesophageal reflux disease
111304883 11130488 2 Blood cholesterol abnormal
111304883 11130488 3 Hyperlipidaemia
111304883 11130488 4 Blood cholesterol abnormal
111304883 11130488 5 Hyperlipidaemia
111304883 11130488 6 Hypertension
111304883 11130488 7 Hypertension
111304883 11130488 8 Hypertension
111304883 11130488 9 Blood cholesterol increased
111304883 11130488 10 Blood pressure abnormal

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
111304883 11130488 Abdominal pain upper
111304883 11130488 Blood cholesterol increased
111304883 11130488 Bone density abnormal
111304883 11130488 Drug dose omission
111304883 11130488 Drug ineffective
111304883 11130488 Feeling abnormal
111304883 11130488 Gastrooesophageal reflux disease
111304883 11130488 Hypersensitivity
111304883 11130488 Intentional product misuse
111304883 11130488 Muscle spasms
111304883 11130488 Nasal congestion
111304883 11130488 Pain
111304883 11130488 Wrong patient received medication

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111304883 11130488 1 2010 0
111304883 11130488 2 2011 0
111304883 11130488 3 2011 0
111304883 11130488 4 2012 0
111304883 11130488 5 2012 0
111304883 11130488 6 2009 0
111304883 11130488 7 1997 0
111304883 11130488 8 201602 0